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Abstract Bovine dopamine ~-monooxygenase was purified from 
each of 18 individual adrenal glands by the method we have 
developed for the rapid purification of the enzyme from a single 
adrenal gland. Differential peptide mapping of the 18 enzyme 
preparations following fluorescence labeling of their cysteine 
residues revealed the presence of a novel variant with Phe as 
residue 208 in 14 adrenal glands; seven of them were homozygous 
for the variant allele and the remaining seven heterozygous. The 
variant enzyme was a tetramer and exhibited kinetic and 
structural properties similar to those of the wild-type tetramer 
(L208)4. These results indicate an allelic polymorphism and co- 
dominant expression of the two alleles of the enzyme gene. 
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I. Introduction 
Dopamine ]3-monooxygenase (EC 1.14.17.1, D[3M) cata- 
lyzes the conversion of dopamine to noradrenaline within ca- 
techolamine secreting vesicles of adrenal medullary cells and 
adrenergic neurons (for reviews, see [1,2]). D]]M also plays an 
essential role in fetal development through noradrenaline bio- 
synthesis [3,4]. Bovine D[3M is a tetramer consisting of two 
disulfide-linked dimers and exists as both soluble and mem- 
brane-bound forms [5-8]. Purified D]3M samples often exhibit 
two or three protein bands as analyzed by SDS-PAGE [9]. 
Since D]3M is encoded by a single-copy gene, the structural 
heterogeneity originates from posttranslational modifications 
such as limited proteolysis and glycosylation. 
The complete primary structure of bovine D[3M has been 
deduced from cDNAs cloned from bovine adrenal glands [10- 
12]. However, the reported sequences are not identical to each 
other. We use the sequence and residue numbering reported 
by Lewis et al. [11] as a standard. Then the following substi- 
tutions were found in the sequences based on cDNAs: 
R198C, E260R, T261D, I262H, A342R, Q443Y, R460E, or 
H581Q. Since each adrenal gland used to isolate cDNA was 
locally acquired, the differences trongly suggest he allelic 
polymorphism of the bovine D[3M gene. In this context, it 
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is interesting that kinetic and structural properties of D[3M 
differ among preparations: Fleming et al. reported relatively 
low values of the equilibrium constant for the association of 
disulfide-linked dimers to tetramer (5.6× 10~-8.3× 108 M -1) 
at pH 5.0 5.5, and non-hyperbolic dependence of the initial 
velocity on tyramine concentration due to reversible nzyme 
oligomerization [13,14]. On the other hand, Klinman et al. 
observed no relationship between kinetic properties and en- 
zyme concentration in the range of 0.1-1000 p-g/ml [2,15]. All 
the D]3M preparations purified by us showed a relatively 
stronger association of dimer to tetramer ([16]; unpublished 
results). These differences in enzyme properties may be due to 
differences in the primary structure of D~M. 
The detailed tertiary and quaternary structures of D[3M are 
not yet elucidated. However, many residues important for the 
enzyme activity have been determined: Y216, H249, H398, 
M473, Y477, and R503 [17 21]. When D~M is fully reduced 
and digested with trypsin, all these residues except for R503 
are found in tryptic fragments containing one or two cysteine 
residues [16]. Thus, comparative mapping of cysteine-contain- 
ing tryptic peptides of various D]3M preparations should be 
effective for screening enetic variants of D[3M with amino 
acid substitutions at positions near the residues essential for 
the activity. 
In this study, we developed a method for rapid purification 
of DI3M from a single adrenal gland, and obtained pure DIeM 
(100-200 p.g) from each of 18 bovine adrenal glands. We 
found that most of the D[3M samples contained a novel tryp- 
tic fragment with the N-terminal sequence of APDV- 
FIPGQQTTYWCYV. We report kinetic and structural prop- 
erties of the variant homo- and heterotetramers of (F208)4 
and (F208)2(L208)2 in comparison with those of the wild- 
type enzyme of (L208)4. 
2. Materials and methods 
2.1. Materials 
Adrenal glands from Japanese black cattle were obtained from a 
slaughterhouse in Kyoto. Tyramine hydrochloride, DTT, TPCK-tryp- 
sin, and Con A-Sepharose were purchased from Sigma; disodium 
fumarate, ascorbic acid, MES, and HEPES were from Nacalai Tes- 
que; I-AEDANS was provided by Research Organics; and catalase 
was obtained as a crystalline suspension (65 000 units/mg) from Boeh- 
ringer Mannheim. All other chemicals used were of analytical grade. 
2.2. Enzyme purification from a s&gle adrenal gland 
The medulla was dissected from a fresh adrenal gland, and homo- 
genized in three volumes of 8 mM potassium phosphate, pH 7.2, 
containing catalase (0.1 mg/ml) [22]. After 20 min incubation in ice- 
water under stirring, the homogenate was centrifuged at16000×g for 
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10 min. The supernatant (crude extract) was subjected to polyethylene 
glycol fractionation according to Ljones et al. [23] in the presence of 
catalase (0.1 mg/ml). The enzyme solution was then applied to a 
DEAE-Toyopearl column (Tosoh, Tokyo; 10X 150 mm) equilibrated 
with 20 mM potassium phosphate, pH 7.5. The flow rate was 1.0 ml/ 
min. After 20 min washing with the same buffer, the enzyme was 
eluted with a linear gradient of 04).5 M NaC1 (8.3 mM/min). The 
active fractions were collected (DEAE-Toyopearl). Aliquots of 2 M 
NaCI and 1 M potassium phosphate, pH 6.5 were added to the sam- 
ple to final concentrations of 0.2 M NaCI and 50 mM potassium 
phosphate, pH 6.5, respectively, and then the sample was applied to 
a Con A-Sepharose column (Pharmacia Biotech; 5×5 mm) equili- 
brated with 50 mM potassium phosphate, pH 6.5, containing 0.2 M 
NaCI. After washing with 10 ml of the same buffer, the gel (about 100 
I11 bed volume) was transferred to two polypropylene micro test tubes 
(1.5 ml). To each tube, an aliquot (0.8 ml) of 50 mM potassium 
phosphate, pH 6.5, containing 0.2 M NaC1 and 0.5 M ct-methyl-D- 
mannoside was added, and the tubes were gently rotated at room 
temperature for 20 min. After centrifugation at 1300xg for 1 min, 
the supernatant was collected. The extraction was carried out three 
times. The combined extracts were concentrated to a final volume of 
151}200 ktl by using a Centriflo CF25 membrane concentrator (Ami- 
con). The concentrate (Con A-Sepharose) was further purified by gel 
filtration on a TSK-GEL G3000SW column (Tosoh, Tokyo; 7.5 X 600 
mm) equilibrated with 25 mM MES, pH 6.0, containing 0.2 M NaC1. 
The flow rate was 0.8 ml/min. The active fractions were collected, and 
concentrated to a final volume of 10~150 ~tl by using microconcen- 
trators (Microcon 30, Amicon). The purified enzyme was stored at 
-80°C until use. 
The protein concentrations of samples during the purification were 
determined with bicinchoninic acid protein assay reagent (Pierce). The 
concentrations of the purified enzyme were determined spectrophoto- 
metrically using E~i= 12.4 [24]. UV-VIS spectra were obtained with a 
Shimadzu UV-2200 spectrophotometer equipped with a Shimadzu 
ultra micro cell holder, and we used 0.1 ml of samples for spectro- 
scopic measurements. 
2.3. Assay of dopamine f~-monooxygenase ctivity 
DIeM activity was assayed at 25°C as the oxygen consumption rate 
using a Yellow Springs model 53 polarographic oxygen electrode 
equipped with a Shimadzu C-R4A integrator to amplify the electrode 
signals, or as the octopamine formation rate using the spectroscopic 
method escribed by Wallace et al. [5] and modified by Ljones et al. 
[23]. In both assays, the standard assay mixtures (2.7 ml for oxygen 
assay and 0.25 ml for octopamine assay) contained 10 mM tyramine, 
10 mM ascorbate, 0.2 mM fumarate [15], 2 IxM CuSO4, 0.1 mg/ml 
catalase, and 50 mM MES buffer (pH 5.1 and ionic strength I= 0.15). 
When the enzyme activities of crude extracts were assayed, N-ethyl- 
maleimide was included in the standard assay mixtures (final concen- 
tration of 30 mM). To obtain kinetic parameters, tyramine concentra- 
tion was varied from 0.1 to 10 mM. 
2.4. Polyacrylamide gel electrophoresis • 
SDS-PAGE was performed on a 7.5% gel according to the method 
of Laemmli [25]. Samples were incubated with 2% SDS and 5% 2- 
mercaptoethanol in 62.5 mM Tris-HC1, pH 6.8, at 70-80°C for 3 min, 
and then subjected to SDS-PAGE. Proteins were stained with Coo- 
massie brilliant blue R-250. 
2.5. Molecular weight determination 
The molecular weights of purified DI3M were determined at 25°C 
by low-angle laser light scattering measurement combined with gel 
chromatography [26]. A TSK-GEL G4000SWxL column (7.8x300 
mm), a UV-8011 uv detector, an LS-8000 low-angle laser light scatter- 
209 
ing photometer, all from Tosoh, and a Shimadzu RID-6A differential 
refractometer were used. The detectors were connected in tandem in 
this order. The buffer was 50 mM MES, pH 5.75, I=0.15, and the 
flow rate was 0.5 ml/min. The molecular mass standards used were 
albumin monomer and dimer (bovine serum, Mr = 66 300 and 132 000, 
respectively), catechol 2,3-dioxygenase (Pseudomonas putida, Mr = 
140000), and glutamate dehydrogenase (yeast, Mr=297000); the 
former two proteins were purified [27,28], the third one was from 
Oriental Yeast, Tokyo. 
2.6. Differential peptide mapping 
Enzyme preparations (10 ktg each) were lyophilized and then re- 
duced at 37°C with 5 mM DTT in 7 M guanidine-HCl, 0.2 M Tris- 
HCI, pH 8.7, and 5 mM EDTA. After 20 min, an equal volume of 20 
mM I-AEDANS was added to label free thiols. After 4 h of incuba- 
tion at 37°C under nitrogen atmosphere, 2-mercaptoethanol (2 ktl) was 
added to the mixture, and it was dialyzed against 1 liter of 50 mM 
sodium phosphate buffer, pH 7.5, at 4°C overnight. After dialysis, an 
equal volume of 8 M urea was added, and then each sample was 
digested with 1 pg of TPCK-trypsin at 25°C for 48 h. Peptide frag- 
ments were separated by reverse-phase HPLC on a Cosmosil 5C18 
column (4.6x250 mm, Nacalai Tesque) at 25°C. Elution was carried 
out with a linear gradient of acetonitrile (0.575% per min and an 
initial concentration of 14%) containing 0.1% trifluoroacetic acid at 
a flow rate of 1 ml/min. Fluorescence at480 nm was monitored with 
excitation at 340 nm by means of a Shimadzu RF-535 fluorescence 
detector. 
To assign cysteine-containing peptide fragments, enzyme samples 
(70-100 Ixg) were labeled with I-AEDANS and digested by the same 
method. The main peptide peaks were collected, and the NH2-ter- 
minal amino acid sequence of each peptide fragment was determined 
using a protein sequencer, Applied Biosystems Model 470A, with an 
on-line PTH amino acid analyzer, Model 120A. 
2. Z Amino acid analysis 
Amino acid analyses were carried out with a Hitachi L-8500 amino 
acid analyzer. The enzyme samples (about 10 p.g) were hydrolyzed in 
the vapor phase of 6 M HC1 containing 0.1% phenol at 110°C for 24 h 
in evacuated reaction vials from Waters Pico Tag work station. To 
determine the protein concentration f the samples used for absorp- 
tion spectroscopy b amino acid analysis, )'-amino-n-butyric acid was 
used as an internal standard. We calculated the enzyme concentration 
using the obtained amino acid contents of Asp, Glu, Gly, Ala, Val, 
lle, Leu, Phe, Lys, His, Arg, and Pro, and the respective amino acid 
contents per subunit of DI3M deduced from cDNA, 42, 68, 41, 41, 39, 
24, 59, 28, 16, 21, 34, and 43. 
2.8. Circular dichroism spectroscopy 
CD spectra were obtained using a Jasco spectropolarimeter, Model 
J-600, at 25°C in 5 mM MES, pH 6.5, containing 0.15 M NaC1. A 
quartz cell with light-path length of 0.1 cm was used and the protein 
concentrations were 0.1~).4 mg/ml. The mean residue ellipticity, 0, 
was calculated using the average residue molecular weight of 112.3 
[11]. 
3. Results 
3.1. Purification of  dopamine [~-monooxygenase from a single 
adrenal gland 
An example of purification of the enzyme from a single 
adrenal gland is given in Table 1. On DEAE-Toyopearl  chro- 
matography, the enzyme activity was eluted as a single peak 
Table 1 
Purification of dopamine 13-monooxygenase from a single bovine adrenal gland 
Purification step Total volume (ml) Total activity (units) Total protein (mg) Specific activity (units/mg) Yield (%) 
Crude extract 9.50 14.3 450 0.03 100 
Polyethylene glycol 1.72 10.3 49.2 0.21 72 
DEAE-Toyopearl 8.95 6.4 3.2 2.0 45 
Con A-Sepharose 0.39 3.4 0.20 17.0 24 
Gel filtration 0.22 2.2 0.13 17.0 15 
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Fig. 1. Identification of a natural variant of dopamine ~-monooxy- 
genase in the enzyme preparations purified from individual adrenal 
glands. A: Reverse-phase HPLC analyses of tryptic fragments con- 
taining AEDANS-labeled cysteine(s) from three different prepara- 
tions on a column of Cosmosil 5C18. B: Steps 4, 5, and 6 of the 
N-terminal sequencing for the peptides P1 and P2. The N-terminal 
17 residues were unambiguously determined for both peptides. 
with about 0.25 M NaC1 (data not shown). Gel filtration on a 
TSK-GEL G3000SW removed trace amounts of contami- 
nated proteins with smaller Stokes radii from the preparation 
obtained by Con A-Sepharose chromatography. The overall 
recovery of the enzyme activity was about 15%, and a suffi- 
cient amount of DI3M (100~300 ~tg) for characterization was 
obtained. 
We purified D[3M from each of 18 individual adrenal 
glands. The specific activities of the purified enzyme were in 
the range of 1540 ~tmol/min/mg, comparable to that of the 
enzyme purified in bulk (about 20 ~tmol/min/mg). It took 
maximally 8 h to obtain pure DI3M from a single adrenal 
gland by the present procedure. 
3.2. Identification of  a novel variant 
To examine mutations in the primary structure of each 
preparation purified separately from 18 single adrenal glands, 
all disulfides of each preparation were reduced with DTT, and 
then the resulting free thiols were labeled with I-AEDANS. 
After TPCK-trypsin digestion, cysteine-containing peptides 
from each enzyme sample were separated by reverse-phase 
HPLC (Fig. 1A). Comparison of the chromatograms obtained 
for the 18 samples revealed that the two peptides (P1 and P2 
in Fig. 1) showed variations in amount among the DI3M pre- 
parations: seven samples contained an equal amount of the 
two peptides (the upper chromatogram in Fig. 1A); four pre- 
parations contained only P1 (the middle chromatogram), 
while the remaining seven samples howed only P2 (the lower 
chromatogram). 
The N-terminal sequence of P1 was determined to be 
APDVLIPGQQTTYWC*YV, where C* is an AEDANS-Ia- 
beled cysteine residue and it could not be detected as a peak 
upon usual PTH-amino acid analysis by a protein sequencer. 
This sequence was identical to sequence 204-220 deduced 
from cDNAs. As shown in Fig. 1B, the fifth residue of the 
N-terminal sequence of P2 was determined to be F, different 
from the L of P1, and all other residues were identical to those 
of P1. 
These results indicate the presence of a novel variant of 
DI]M with F as residue 208, and that there are three pheno- 
types of D~M in Japanese black cattle, viz. L208 homoen- 
zyme (L/L), F208 homoenzyme (F/F), and L208/F208 hetero- 
enzyme (L/F). 
3.3. Characterization of  the variant dopam&e 
~-monooxygenase 
D[3M preparations purified in bulk exhibit three protein 
bands on SDS-PAGE under reducing conditions [9]. As 
shown in Fig. 2A, all of the wild-type, variant and heteroen- 
zyme (L/L, F/F, and L/F) were separated into one major band 
of 76 kDa and two additional bands of 79 and 73 kDa. The 
result shows that the heterogeneity of D[3M is due to post- 
transcriptional modifications. 
The molecular weights of L208 homoenzyme, F208 homo- 
enzyme, and L208/F208 heteroenzyme w re determined to be 
2.3x 105, 2.2x 105, and 2.5x 105, respectively, by low-angle 
laser light scattering photometry coupled with high-perfor- 
mance gel chromatography (Fig. 2B). Since the subunit mo- 
lecular weight estimated from eDNA is 6.5X 104, the result 
shows that all three types of DI]M are a tetramer. 
The conformations of the three types of DIeM were inves- 
tigated by CD spectroscopy (Fig. 2C). The observed CD spec- 
tra were similar to each other: they showed a deep trough at 
214 nm and a shallow trough at 242 nm. No significant dif- 
ference was found among the absorption spectra of the three 
phenotypes (Fig. 2D). They showed a peak at 278 nm with the 
molar absorption coefficient of about 8.65x 104 M-a.cm -1. 
The value agreed well with that commonly used for bovine 
DI3M (8.99 X 104 M-l.cm -1) [24], and significantly arger than 
that calculated on the basis of the bovine cDNA derived se- 
quences (6.49 x 104 M-l.cm -1) [29]. 
No significant difference was found among the amino acid 
compositions of the wild-type, variant, and heteroenzyme. 
The compositions agreed with those predicted from the nu- 
cleotide sequences [10-12] within experimental errors (data 
not shown). 
3.4. Kinetic parameters 
To compare kinetic properties of the three types of D~M, 
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Fig. 2. Structural and spectral characterization f the wild-type (L/L), variant (F/F), and heteroenzymes (L/F) of dopamine !3-monooxygenase. 
A: SDS-PAGE of the marker proteins (lane 1), L/L enzyme (1.0 gg, lane 2), F/F enzyme (1.0 gg, lane 3), L/F enzyme (1.0 gg, lane 4), and 
mixture of L/L and F/F (both 0.5 gg, lane 5). B: Molecular weight determination. The ratio of the output of the light scattering photometer 
(LS) to that of the differential refractometer (RI) was plotted against molecular weight. The enzyme concentrations at the elution peak were 
4.5 gg/ml for L/L, 5.8 lag/ml for F/F, and 6.5 lag/ml for L/F. C: Far-UV circular dichroism spectra. The protein concentrations were 0.4 mg/ml 
for the two homoenzymes and 0.1 mg/ml for the heteroenzyme. D: Absorption spectra. Spectra were obtained in 10 mM MES, pH 6.5, con- 
taining 0.2 M NaC1. 
we performed kinetics for each of the 18 DI]M preparations 
(Fig. 3). All of the preparations howed a hyperbolic depen- 
dence of the initial velocity on tyramine concentration. We 
could not found any significant difference in kinetic properties 
among the three phenotypes of D[3M. 
4. Discussion 
In the present study we have isolated a novel variant 
of bovine dopamine [3-monooxygenase arising from a 
Leu2°8~Phe substitution. This is probably due to a point 
mutation, CTC~TTC,  at position 634 in the DI]M gene, 
although a mutation of CTC ~ TTT is also possible. The var- 
iant subunit was found in 14 out of 18 adrenal glands exam- 
ined, suggesting an allelic polymorphism of the DI]M gene in 
Japanese black cattle. Seven adrenal glands were heterozygous 
for the variant, and all of them contained an equal amount of 
the variant (F208) and the wild-type (L208) subunit. 
We searched five D[3M preparations purified in bulk for the 
variant. Various amounts of the variant (10-50%) were found. 
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Fig. 3. Kinetic parameters for dopamine [3-monooxygenase prepara- 
tions individually purified from a single adrenal gland. The activities 
were assayed at 25°C in 50 mM MES, pH 5.1, I=0.15. The reac- 
tions were initiated by adding 0.2 lag of the enzyme into 0.25 ml of 
reaction mixtures. The values of kinetic parameters were obtained 
from [S]/v versus [S] plots, where [S] is the tyramine concentration 
and v the initial velocity. 
We purified the enzyme from a commercially available D[3M 
preparation (Sigma, Lot 95H7100), and examined the variant 
content. This sample contained only the wild-type protein 
(L208). These results imply that chromatographic methods 
used for DI3M purification cannot separate the three pheno- 
types of L/L, L/F, and F/F. 
Since the residue Y216 is essential for the activity [17] and 
Phe is a bulky aromatic residue, the substitution from alipha- 
tic Leu to Phe at position 208 near Y216 may be expected to 
affect the active site environment of D[3M. However, the var- 
iant exhibited essentially identical kinetic properties compared 
to those of the wild-type enzyme. The result suggests that 
residue 208 does not participate in the active site structure, 
or that the structure around the active site is flexible to ac- 
commodate the perturbation induced by the substitution. 
Two allelic forms of human dopamine [3-monooxygenase 
with either alanine or serine at position 304 were cloned 
from a cDNA library [30], and it was reported that 304S 
DI3M was one-tenth less active than 304A DI3M [31]. How- 
ever, the recent report shows that the recombinant 304S is not 
significantly different from the recombinant 304A in kinetic 
and other enzyme properties [32]. Since human plasma con- 
tains about 10/.tg/ml D[3M [33], it is possible to screen genetic 
variants of DI3M not only by genetic technology but also by 
protein chemical methods used in the present study. A rapid 
purification of DI3M from human plasma (1-10 ml) with high 
yields is now under development in our laboratory. 
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